Lemborexant to help Sleep and Delirium in older ICU patients
Official title: Lemborexant for Sleep Promotion and Delirium Prevention in Critically Ill Adults: A Combined Feasibility-Pilot, Randomized, Double-Blind, Placebo-Controlled Trial
Run by Mahidol University · NCT07407400 · Data updated 2026-11-12
This study tests whether lemborexant, a sleep medication, helps improve sleep and reduce delirium in adults 65 and older in the ICU.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Mahidol University Academic / other |
| Locations | 1 site (Bangkok) |
| Status | Recruiting |
| Started | September 1, 2026 |
| Main results expected | December 31, 2027 |
| Study ends | June 30, 2028 |
| Registry record updated | October 8, 2026 |
| Trial ID | NCT07407400 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 65 or older admitted to the Surgical ICU with an anticipated stay of at least 48 hours and able to receive enteral medication.
✕Probably not a fit
Patients with frequent neurological checks, deep sedation, recent CAM-ICU positivity, severe instability, high aspiration risk, or those on certain interacting medications may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This Phase 4, single-center trial will compare lemborexant to placebo in elderly surgical ICU patients who have at least 48 hours of expected stay. The study focuses on sleep quality and delirium outcomes, with safety monitored in a critically ill population. Eligible participants must be able to take medications by mouth or via a tube and meet specific health criteria. The trial aims to determine if this sleep drug can be safely used in the SICU to potentially improve recovery.
Why it matters
Potential benefit: If successful, patients may experience better sleep and a lower risk of delirium during their ICU stay.
How similar studies have gone: Previous sleep aids have shown mixed results in ICU patients; this study explores a targeted dual orexin receptor antagonist in a critically ill elderly population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 65 years or older. * Admission to the Surgical Intensive Care Unit (SICU). * Anticipated ICU stay of at least 48 hours, as assessed by the ICU consultant and responsible surgeon. * Able to receive enteral medication via oral or nasogastric route. Exclusion Criteria: * Requirement for frequent neurological checks or scheduled awakening (e.g., acute stroke or neurosurgery). * Deep sedation defined as Richmond Agitation-Sedation Scale (RASS) ≤ -3. * Positive Confusion Assessment Method for the ICU (CAM-ICU) within 12 hours prior to randomization. * Severe hemodynamic or respiratory instability requiring neuromuscular blockers or high-dose vasopressors (e.g., norepinephrine ≥ 0.1 µg/kg/min and titrating upward). * High risk of aspiration, including ongoing vomiting, gastric residual volume \>250 mL, or intolerance to oral or enteral medications. * Concomitant use of strong CYP3A inhibitors or inducers (e.g., ketoconazole, itraconazole, clarithromycin, ritonavir, rifampicin, carbamazepine, phenytoin, or St. John's wort). * Severe hepatic impairment (Child-Pugh class C). * End-stage kidney disease or chronic kidney disease stage 5. * Concomitant use of sedative-hypnotic medications, including benzodiazepines, Z-drugs, trazodone, tricyclic antidepressants, melatonin, or other sleep-inducing agents. * Known hypersensitivity to lemborexant or other dual orexin receptor antagonists. * History of cataplexy-like symptoms or severe depression with suicidal ideation.
Where it's running
-
Siriraj Hospital
Bangkok, Thailand Recruiting
Study contacts
- Principal investigator: Nuanprae Kitisin — Department of Anesthesiology, Faculty of Medicine, Siriraj Hospital, Mahidol University
- Study coordinator: Nuanprae Kitisin, MD
- Email: nuanprae.kit@mahidol.ac.th
- Phone: +66896767706
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Combining sleep promotion and cognitive training to improve brain function in older ICU survivors
This study is testing if helping older adults who survived ICU treatment sleep better and do brain exercises can improve their thinking skills.
-
Listening to music to prevent delirium in older adults in the ICU
This trial will try whether personalized or relaxing music, played twice daily for a week, can prevent delirium and increase days alive and free of delirium or coma in adults 65 and older in the ICU.
-
Investigating sleep and circadian rhythm in critically ill children
This study is testing if giving critically ill children in the PICU more light during the day and limiting their food to daytime hours can help improve their sleep patterns.
-
Improving ICU care through behavioral strategies
This study is testing two strategies to help ICU staff use better practices for caring for critically ill adults, especially those facing health challenges, to see if it can improve patient recovery and reduce complications.
-
Using AI and sensors to monitor critically ill patients in the ICU
This study is testing whether using AI and sensors can help doctors better monitor and understand the health of critically ill patients in the ICU.
-
Understanding brain health in ICU patients with kidney injury
This study looks at how kidney injury affects brain health in critically ill adults in the ICU to see if measuring brain oxygen levels can help predict long-term thinking and memory problems.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.